Keiichi Mitsuyama Selected Research

Keiichi Mitsuyama Research Topics

Disease

38	Ulcerative Colitis 11/2022 - 01/2002
23	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 05/2005
21	Colitis 11/2020 - 01/2002
16	Crohn Disease (Crohn's Disease) 11/2022 - 01/2006
12	Inflammation (Inflammations) 01/2020 - 01/2002
8	Neoplasms (Cancer) 01/2022 - 02/2010
5	Body Weight (Weight, Body) 01/2011 - 01/2003
3	Intestinal Diseases (Diseases, Intestinal) 05/2020 - 04/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 11/2009
3	Colonic Neoplasms (Colon Cancer) 04/2013 - 10/2008
3	Colorectal Neoplasms (Colorectal Cancer) 07/2011 - 01/2006
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 03/2018
2	Autoimmune Hepatitis 01/2022 - 10/2018
2	Ulcer 09/2021 - 03/2014
2	Pain (Aches) 10/2020 - 07/2020
2	Abdominal Pain (Pain, Abdominal) 10/2015 - 04/2010
2	Malnutrition (Nutritional Deficiencies) 11/2009 - 11/2009
2	Carcinogenesis 01/2009 - 10/2008
1	Disease Progression 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Wounds and Injuries (Trauma) 09/2021
1	COVID-19 11/2020
1	Pediatric Crohn's disease 05/2020
1	Jaundice (Icterus) 10/2018
1	Lung Neoplasms (Lung Cancer) 08/2018
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 09/2021 - 06/2004
11	PrebioticsIBA 10/2013 - 01/2002
9	Dextran SulfateIBA 11/2020 - 01/2003
8	Therapeutic UsesIBA 04/2013 - 01/2002
7	EnzymesIBA 03/2018 - 01/2006
7	Proteins (Proteins, Gene)FDA Link 06/2013 - 02/2002
5	SteroidsIBA 01/2021 - 04/2011
5	Dextrans (Dextran)FDA Link 01/2020 - 01/2002
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2002
5	Interleukin-6 (Interleukin 6)IBA 02/2010 - 01/2003
4	Peptides (Polypeptides)IBA 09/2021 - 01/2005
4	AntibodiesIBA 05/2020 - 06/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 12/2004
4	ImmunosorbentsIBA 01/2018 - 01/2006
4	Butyrates (Butyrate)IBA 01/2011 - 01/2002
3	AdrenomedullinIBA 11/2022 - 09/2016
3	Myeloblastin (Proteinase 3)IBA 01/2022 - 03/2018
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 03/2018
3	AcidsIBA 09/2021 - 02/2006
3	Macrophage Migration-Inhibitory FactorsIBA 06/2012 - 01/2008
3	Volatile Fatty AcidsIBA 07/2011 - 01/2003
3	Glutamine (L-Glutamine)FDA Link 11/2003 - 01/2003
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	SolutionsIBA 09/2021 - 01/2008
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2020
2	CurcuminIBA 12/2020 - 12/2006
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 10/2018 - 02/2012
2	theasinensin AIBA 06/2018 - 09/2011
2	Pharmaceutical PreparationsIBA 09/2017 - 10/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 02/2002
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 12/2011 - 04/2009
2	AzoxymethaneIBA 07/2011 - 10/2008
2	Serotonin (5 Hydroxytryptamine)IBA 01/2011 - 04/2010
2	Interferon-gamma (Interferon, gamma)IBA 01/2011 - 01/2008
2	Branched-Chain Amino AcidsIBA 11/2009 - 11/2009
2	Dietary Fiber FDA Link 11/2003 - 01/2003
1	Biological ProductsIBA 11/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 09/2021
1	HydrogelsIBA 09/2021
1	RADA16-IIBA 09/2021
1	CollagenIBA 09/2021
1	Peroxidase (Myeloperoxidase)IBA 06/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Interleukin-22 (IL-22)IBA 12/2020
1	DefensinsIBA 12/2020
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2020
1	Transient Receptor Potential ChannelsIBA 08/2020
1	GlucansIBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2018
1	NivolumabIBA 08/2018
1	Immune Checkpoint InhibitorsIBA 08/2018
1	IronIBA 09/2017
1	Drinking WaterIBA 09/2017
1	Coloring Agents (Dyes)IBA 09/2017
1	Antisense OligonucleotidesIBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015
1	Bevacizumab (Avastin)FDA Link 10/2015
1	Carboplatin (JM8)FDA LinkGeneric 10/2015

Therapy/Procedure

19	Therapeutics 01/2020 - 12/2004
6	Blood Component Removal (Apheresis) 10/2020 - 04/2005
2	Punctures 10/2020 - 07/2020
2	Colectomy 07/2020 - 10/2015
2	Oral Administration 01/2011 - 01/2002
1	Renal Dialysis (Hemodialysis) 10/2020
1	Time-to-Treatment 07/2020